Racial Disparities in Periprosthetic Joint Infections after Primary Total Joint Arthroplasty: A Retrospective Study

• Published in: Antibiotics (Basel) Vol. 12; no. 11; p. 1629
• Main Authors: Pinkney, Jodian A, Davis, Joshua B, Collins, Jamie E, Shebl, Fatma M, Jamison, Matthew P, Acosta Julbe, Jose I, Bogart, Laura M, Ojikutu, Bisola O, Chen, Antonia F, Nelson, Sandra B
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.11.2023
• Subjects: Age; Analysis; Arthroplasty; Comorbidity; Complications; Confidence intervals; Datasets; Diabetes; Ethnicity; Health aspects; Health care access; health equity; Hispanic people; Inequality; Infection; Infections; Joint diseases; Joint surgery; Mediation; Mediators; Medical records; Patients; periprosthetic joint infection; Race; Race factors; Racial differences; racial disparities; Software; Statistical analysis; Variables; Weight control; Massachusetts; United States > US; racial disparities; periprosthetic joint infection; health equity; arthroplasty
• ISSN: 2079-6382; 2079-6382
• DOI: 10.3390/antibiotics12111629

In the United States, racial disparities have been observed in complications following total joint arthroplasty (TJA), including readmissions and mortality. It is unclear whether such disparities also exist for periprosthetic joint infection (PJI). The clinical data registry of a large New England hospital system was used to identify patients who underwent TJA between January 2018 and December 2021. The comorbidities were evaluated using the Elixhauser Comorbidity Index (ECI). We used Poisson regression to assess the relationship between PJI and race by estimating cumulative incidence ratios (cIRs) and 95% confidence intervals (CIs). We adjusted for age and sex and examined whether ECI was a mediator using structural equation modeling. The final analytic dataset included 10,018 TJAs in 9681 individuals [mean age (SD) 69 (10)]. The majority (96.5%) of the TJAs were performed in non-Hispanic (NH) White individuals. The incidence of PJI was higher among NH Black individuals (3.1%) compared with NH White individuals (1.6%) [adjusted cIR = 2.12, 95%CI = 1.16-3.89; = 0.015]. Comorbidities significantly mediated the association between race and PJI, accounting for 26% of the total effect of race on PJI incidence. Interventions that increase access to high-quality treatments for comorbidities before and after TJA may reduce racial disparities in PJI.